Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.

Mundipharma

Status: Withdrawn

Conditions: Asthma

Treatments: Other: Observational. Non interventional study

Study type: Observational

Funder types: Industry

Identifiers

NCT02811315

FLT9509

Details and patient eligibility

About

The objective of the study is to evaluate the effect of frequency of use with a spacer on asthma control in Dutch patients with asthma during their daily clinical practice over 12 weeks treatment.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients eligible to be prescribed fluticasone/formoterol fixed dose combination as follows:

Patients not adequately controlled in inhaled corticosteriods and "as required" inhaled short acting beta 2 agonist or patients already adequately controlled on both an inhaled corticosteriod and a long-acting beta 2 agonist.

The decision to prescribe fluticasone/formoterol fixed dose combination will precede and be independent of the decision to enroll the patient into the study

Exclusion criteria

• There are no specific exclusion criteria as this is an observational study